Citius Oncology Inc. (NASDAQ:CTOR) develops and commercializes innovative targeted oncology therapies. It also develops LYMPHIR, an orphan indication for the treatment of adult patients with relapsed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results